Eastman Chemical (EMN) Director Awarded Phantom Stock Units
EASTMAN CHEMICAL CO
Subscribe to track EMN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Eastman Chemical (EMN) Director Awarded Phantom Stock Units
Company: EASTMAN CHEMICAL CO (EMN) Form: 4 | Filed: 2025-10-09 Significance: Low
Insider: BUTLER ERIC L Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 487 Phantom Stock Units • Price: $0.00 • Value: $0 • Owned After: 2,768 units
Key Insight: This is a routine, non-cash transaction representing an automatic deferral of a portion of the director's annual retainer fees into phantom stock units, as part of a compensation plan. It does not reflect a discretionary investment decision.
Market Context: Such compensation-related grants are common for directors and typically do not influence market sentiment as they are not open-market trades.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: EASTMAN CHEMICAL CO (EMN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received phantom stock units as part of a standard deferred compensation plan. This is a routine, non-discretionary transaction with no cash value at the time of the award and does not signal a change in insider sentiment.
- Market Impact: Neutral. This type of transaction is a common form of director compensation and is not expected to have any material impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | EASTMAN CHEMICAL CO |
| Ticker Symbol | EMN |
| CIK | 0000915389 |
| Industry | Plastics, Materials, Synth Resins & Nonvulcan Elastomers [2821] |
Insider Information
| Field | Value |
|---|---|
| Name | BUTLER ERIC L |
| CIK | 0001544184 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-07 |
| Transaction Code | A (Grant, award, or other acquisition) |
| Security Type | Phantom Stock Units |
| Shares Involved | 487 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 2768 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is an award (Code 'A') with a price of $0.00, indicating it's part of a compensation package rather than an open-market purchase. The filing's footnotes confirm this is an automatic deferral of director fees. Such events are pre-planned and do not provide new information about the insider's view on the company's valuation.
Volume & Sentiment
- Expected Volume Impact: None. As this is not an open-market transaction, it will not directly affect trading volume.
- Sentiment Indicator: Neutral. The market generally disregards routine compensation-related grants when assessing insider sentiment.
Investment Insights
Positive Market Indicators
- The grant aligns the director's interests with shareholders by increasing their equity-linked holdings, although it's a routine part of compensation.
Risk Factors
- No direct risk factors are indicated by this filing. It is a standard corporate governance procedure.
Key Takeaways
- Routine Compensation: The transaction is an automatic deferral of director fees into phantom stock units, not a discretionary investment.
- No New Signal: This filing does not provide any new bullish or bearish signals regarding the company's future prospects.
- Cash Settlement: The phantom stock units are payable only in cash after the director's service terminates, meaning they will not convert to common stock on the open market.
Contextual Analysis
Timing Significance
- The timing of the grant is likely tied to a regular compensation schedule (e.g., quarterly or annual retainer payments) and not to any specific market event or internal knowledge.
Transaction Context
- Footnote F2 explicitly states this is an "Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash." This confirms the non-discretionary and routine nature of the acquisition.
- Footnote F1 clarifies that these are phantom units, payable in cash, not common stock.
Company Context
- This filing should be viewed in the context of Eastman Chemical's standard director compensation policies. Without other significant insider buys or sells, this transaction holds little predictive value.
Risk Assessment
Risk Level: Low
Risk Factors
- This specific filing presents no discernible risks to investors.
Market Considerations
- Investors should focus on fundamental analysis, earnings reports, and significant open-market insider transactions rather than routine compensation grants like this one.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-09 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
